Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Conditions

Warts 3Condylomata Acuminata 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Cantharidin × Clear all
NCT05070754 2024-04-05

Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca

Medical University of South Carolina

Phase 4 Completed
17 enrolled 13 charts

Warts

NCT03625960 2018-08-10

Cantharone for the Treatment of Perenial Warts

Wayne State University

Phase 4 Completed
12 enrolled

Condylomata Acuminata, Warts

NCT01084824 2010-03-11

A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin

North Idaho Dermatology

Phase NA Completed
70 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡